Romagnolo, Alberto http://orcid.org/0000-0002-1312-1843
Zibetti, Maurizio
Merola, Aristide
Canova, Daniela
Sarchioto, Marianna
Montanaro, Elisa
Artusi, Carlo Alberto
Vallelonga, Fabrizio
Maule, Simona
Lopiano, Leonardo
Article History
Received: 21 August 2018
Revised: 22 October 2018
Accepted: 23 October 2018
First Online: 31 October 2018
Compliance with ethical standards
:
: Dr Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Medtronic, Lusofarmaco and UCB Pharma. Dr Zibetti has received speaker’s honoraria from Medtronic, Chiesi Farmaceutici, UCB Pharma, and AbbVie. Dr Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Abbvie, and Cynapsus Therapeutics. He has received grant support from Lundbeck. Dr Canova reports no disclosures. Dr Sarchioto reports no disclosures Dr Montanaro reports no disclosures. Dr Artusi reports no disclosures. Dr Vallelonga reports no disclosures. Dr Maule reports no disclosures. Dr Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma and AbbVie.
: A. Romagnolo had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
: The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The local institutional review board (Comitato Etico Interaziendale Città della Salute e della Scienza di Torino; Protocol n° 0050175/CEI-715) approved the study and all participants provided written informed consent.